ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $822,000 | -11.1% | 13,330 | +5.0% | 0.00% | 0.0% |
| Q3 2019 | $925,000 | -12.2% | 12,691 | -0.9% | 0.00% | 0.0% |
| Q2 2019 | $1,053,000 | +8.3% | 12,806 | -7.0% | 0.00% | 0.0% |
| Q1 2019 | $972,000 | +47.5% | 13,777 | -5.9% | 0.00% | 0.0% |
| Q4 2018 | $659,000 | +231.2% | 14,640 | +388.5% | 0.00% | – |
| Q2 2018 | $199,000 | +5.9% | 2,997 | -7.4% | 0.00% | -100.0% |
| Q1 2018 | $188,000 | -10.9% | 3,236 | -1.4% | 0.00% | – |
| Q4 2017 | $211,000 | +9.9% | 3,281 | -10.4% | 0.00% | – |
| Q3 2017 | $192,000 | +23.1% | 3,663 | +9.8% | 0.00% | – |
| Q2 2017 | $156,000 | -9.3% | 3,337 | -4.5% | 0.00% | -100.0% |
| Q1 2017 | $172,000 | +47.0% | 3,493 | +82.3% | 0.00% | – |
| Q4 2016 | $117,000 | -32.0% | 1,916 | -25.9% | 0.00% | -100.0% |
| Q3 2016 | $172,000 | +168.8% | 2,587 | +59.0% | 0.00% | – |
| Q3 2015 | $64,000 | – | 1,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |